Kenneth Fallon, III Biography and Net Worth

Director of Conformis


Mr. Fallon has served as a member of our board of directors since January 2005, including as Chairman of our board of directors since February 2015. Mr. Fallon retired from active employment in March 2003. From time to time between March 2004 to June 2009, Mr. Fallon served as an advisor to Kairos Partners, an investment firm. Mr. Fallon retired as the chairman of the board of Axya Medical, Inc., a medical device company, in March 2003. Prior to that, Mr. Fallon also served as the chief executive officer of Axya Medical, Inc.; as president of the surgical business at Haemonetics Corporation, a manufacturer of blood processing technology; as chief executive officer and chairman of the board of UltraCision, Inc., a developer and manufacturer of ultrasonically powered surgical instruments; as president and chief executive officer of American Surgical Technologies Corporation, a company that manufactures laparoscopic viewing systems; as president, U.S. operations of Zimmer, Inc., a joint replacement company and then a subsidiary of Bristol-Myers Squibb Company; as president of Zimmer’s Orthopaedic Implant Division and as its vice president of marketing and positions of significant responsibility with the Codman and Orthopaedic Divisions of Johnson & Johnson, a global healthcare company. Mr. Fallon also served as a member of the board of directors of Osteotech, Inc.,a company that produces bone graft materials for spinal procedures, between 1995 and 2010, including serving as chairman from April 2005 to August 2010, until it was acquired by Medtronic, Inc. Mr. Fallon has a B.B.A. degree in marketing from the University of Massachusetts and an M.B.A. from Northeastern University.

What is Kenneth P. Fallon, III's net worth?

The estimated net worth of Kenneth P. Fallon, III is at least $23,042.96 as of May 10th, 2021. Mr. Fallon, III owns 10,196 shares of Conformis stock worth more than $23,043 as of March 28th. This net worth evaluation does not reflect any other investments that Mr. Fallon, III may own. Learn More about Kenneth P. Fallon, III's net worth.

How do I contact Kenneth P. Fallon, III?

The corporate mailing address for Mr. Fallon, III and other Conformis executives is 600 TECHNOLOGY PARK DRIVE, BILLERICA MA, 01821. Conformis can also be reached via phone at (781) 345-9001 and via email at [email protected]. Learn More on Kenneth P. Fallon, III's contact information.

Has Kenneth P. Fallon, III been buying or selling shares of Conformis?

Kenneth P. Fallon, III has not been actively trading shares of Conformis during the last ninety days. Most recently, on Monday, May 10th, Kenneth P. Fallon III bought 800 shares of Conformis stock. The stock was acquired at an average cost of $23.00 per share, with a total value of $18,400.00. Following the completion of the transaction, the director now directly owns 10,196 shares of the company's stock, valued at $234,508. Learn More on Kenneth P. Fallon, III's trading history.

Who are Conformis' active insiders?

Conformis' insider roster includes J. Alldredge (Insider), Mark Augusti (CEO), Kenneth Fallon, III (Director), and Robert Howe (CFO). Learn More on Conformis' active insiders.

Kenneth P. Fallon, III Insider Trading History at Conformis

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/10/2021Buy800$23.00$18,400.0010,196View SEC Filing Icon  
8/17/2016Sell160$211.00$33,760.003,688View SEC Filing Icon  
See Full Table

Kenneth P. Fallon, III Buying and Selling Activity at Conformis

This chart shows Kenneth P Fallon III's buying and selling at Conformis by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Conformis Company Overview

Conformis logo
Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, iTotal CR, and iTotal PS, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also offers Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, Brazil, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.
Read More

Today's Range

Now: $2.26
Low: $2.25
High: $2.27

50 Day Range

MA: $2.25
Low: $2.22
High: $2.26

2 Week Range

Now: $2.26
Low: $1.05
High: $7.25

Volume

7,000 shs

Average Volume

99,585 shs

Market Capitalization

$17.80 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.39